Skip to main content

Table 1 Eligibility criteria

From: Impact of exercise training on cardiotoxicity and cardiac health outcomes in women with breast cancer anthracycline chemotherapy: a study protocol for a randomized controlled trial

Inclusion criteria

Exclusion criteria

Female gender

Contraindications to maximal exercise testing

Decompensated diabetes mellitus

Aged 18 years or older

Severe anemia (hemoglobin < 8 g/dL) uncorrectable with transfusion and/or iron and/or vitamin deficiency replacement

Pregnancy

Histological diagnosis of stage IA–IIIC breast carcinoma

Known significant heart disease (myocardial infarction, congestive heart failure, cardiomyopathy)

Scheduled to receive AC-CT

Usual medication containing beta-blockers

Follow up at the Medical Oncology clinic at the CHVNG/E

 

Consent of the assistant oncologist for the practice of exercise

 

Able to provide informed consent

 

Acceptance of randomization to intervention group or control group

 
  1. AC-CT anthracycline-containing chemotherapy, CHVNG/E Centro Hospitalar de Vila Nova de Gaia/Espinho